Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry [Yahoo! Finance]
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Standard BioTools (NASDAQ:LAB) had its price target lowered by analysts at TD Cowen from $1.55 to $1.35. They now have a "hold" rating on the stock.
Standard BioTools Reports Third Quarter 2025 Financial Results
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025